Reporter

Kayvon Modjarrad, M.D., Ph.D., director of Emerging Infectious Disease Threats at the Walter Reed Army Institute of Research in Silver Spring, Maryland, will be the keynote speaker Sept. 25 at a forum entitled “Global Health at Vanderbilt.”

A certain genetic variant, in combination with the use of anti-inflammatory drugs like aspirin and ibuprofen during early pregnancy, may protect women from miscarriage.

Aetna announces a new accountable care product, Aetna Whole Health — Tennessee, which leverages the strengths of the Vanderbilt Health Affiliated Network, a collaborative partnership of physicians, health systems, and employers in Tennessee and surrounding states. The new product will provide employers a value-based health care option designed to increase quality, improve efficiency and the patient experience and control costs.

Facilitated reporting of medication-related events in the intensive care unit can provide opportunities for optimizing quality of care and patient safety.

An enzyme in the gut – NAPE-PLD – is required for the action of signaling molecules that reduce food intake and weight gain.